Industries > Pharma > Blood Culture Tests Market Report 2019-2029

Blood Culture Tests Market Report 2019-2029

Analysis by Application (Bacteremia, Fungemia), Product (Consumables, Instrument), Method (Automated, Manual), Technology (PCR, Microarray, Proteomic) and End User (Hospital Laboratories, Reference Laboratories), Plus Company and Country Analysis and Forecasts

PAGES: 201
PRODUCT CODE: PHA0427
SUBMARKET: Diagnostics Pharma

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0427 Categories: , , Tag:

Market Definition:
• Blood culture tests play a vital role in diagnosis of bacterial, fungal, and mycobacterial among other infections. Various techniques, including conventional/manual and automated blood culture methods, are used by healthcare professionals for the detection of infection.
• To determine the best treatment, blood culture tests can help identify the type of microorganism that is causing an infection.
• Using sterile technique, a sample of blood is placed in a culture media and incubated in a controlled environment for 1 to 7 days. If microorganisms grow they can be identified and tested.

Market Overview and Trends
• The high growth of blood culture tests market is attributed to the quick turnaround time, reduced risk of contamination, and low manual intervention required in automated blood culture
• The technological advancement has led to instruments and software innovation and this will create new opportunities for manufacturers of the blood culture tests market in the coming years.

Market Dynamics:

Factors Influencing the Market Growth:
• Rising prevalence of infectious diseases such as BSIs and sepsis is expected to be main driving factor for the growth of blood culture tests market.
• The increasing number of regulatory approvals and new product launches has enhanced the market growth.
• High demand for advanced products by hospitals and clinical diagnostics laboratories for the detection of bacterial, fungal, and mycobacterial infections is expected to be the driving factor of blood culture tests market.

Factors Restraining the Market Growth:
• The diagnostic products, such as instruments, kits, reagents, media, and assays, undergo rigorous clinical trials prior to a regulatory approval. Stringent government regulations for the development and manufacturing of diagnostic products, including blood culture tests products, could hinder the market growth.

Market Segmentation 2019-2029:
The blood culture test market is segmented on the method, application, product, technology, end user, and geography.

Method
• Manual Methods Market, 2019-2029
• Automated Methods Market, 2019-2029

Application
• Bacteremia Market, 2019-2029
• Fungemia Market, 2019-2029
• Mycobacterial Detection Market, 2019-2029

Product
• Consumables Market, 2019-2029
– Blood Culture Media Market, 2019-2029
– Assay Kits & Reagents Market, 2019-2029
– Blood Culture Accessories Market, 2019-2029
• Instruments Market, 2019-2029
– Automated Blood Culture Systems Market, 2019-2029
– Supporting Laboratory Equipment Market, 2019-2029
• Software and Services Market, 2019-2029

Technology
• Culture-Based Technology Market, 2019-2029
• Molecular Technologies Market, 2019-2029
• Proteomics Technology Market, 2019-2029

End User
• Hospital Laboratories Market, 2019-2029
• Reference Laboratories Market, 2019-2029
• Academic Research Laboratories Market, 2019-2029
• Others Laboratories Market, 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Blood Culture Tests market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Becton, Dickinson and Company, Biomérieux SA, Thermo Fisher Scientific, Inc., Cepheid, Nanosphere, Inc., Danaher Corporation, Luminex Corporation, Roche Diagonistics, Bruker Corporation, T2 Biosystems, and Abbott Laboratories

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Blood Culture Tests Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Blood Culture Tests Market Report 2019-2029


Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

READ

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

READ

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

READ

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

READ

Categories

Category